LEUPEPTIN READY MADE SOLUTION

Catalog No.: C005B-317353
Mfr. No.: SAE0153-1ML
Mfr. Name: Sigma-Aldrich
Qty/UOM: 1
UOM: ML

Price: $328.55

List Price: $365.06

General description Leupeptin is a tripeptide protease inhibitor that is naturally produced in Actinomyces / Streptomyces . Known also as N -acetyl-L-leucyl-L-leucyl-L-arginal, leupeptin is a reversible competitive inhibitor of cysteine,

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

General description

Leupeptin is a tripeptide protease inhibitor that is naturally produced in Actinomyces / Streptomyces. Known also as N-acetyl-L-leucyl-L-leucyl-L-arginal, leupeptin is a reversible competitive inhibitor of cysteine, serine, and thiol proteases.

Features and Benefits

Inhibitor of serine and cysteine proteases
Inhibits plasmin, trypsin, papain, calpain, and cathepsin B
Does not inhibit pepsin, cathepsin A, cathepsin D, thrombin, or α-chymotrypsin
Effective concentration: 10 μM - 100 μM
Convenient 5 mM non-freezing solution, ready to dilute to the desired working concentration

UPC:: 51183800
Condition:: New
Availability:: 3-5 Days
Weight:: 1.00 Ounces
HazmatClass:: No
MPN:: SAE0153-1ML

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."